insights_auto
Nega EVT tushdi 8,76%?
Batafsil oʻrganishchevron_right
EVT:FRA
Evotec SE
2,83 €
arrow_downward
-8,76%(-0,27) 1K
7-okt, 14:02:32 (GMT+2) · EUR
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoEVT tikeri uchun statistika yaratilmoqda...
Ochish
2,96 €
Yuqori
2,96 €
Past
2,83 €
Bozor kapitali
489,02Â mln
Oʻrtacha hajm
4,58Â ming
Hajmi
1,90Â ming
52 haftalik eng yuqori
7,49 €
52 haftalik eng past
2,73 €
Aksiya boʻyicha daromad
-1,11 €
Muomaladagi aksiyalar
148,72Â mln
Xodimlar soni
4Â ming
Ochish
2,96 €
Yuqori
2,96 €
Past
2,83 €
Bozor kapitali
489,02Â mln
Oʻrtacha hajm
4,58Â ming
Hajmi
1,90Â ming
52 haftalik eng yuqori
7,49 €
52 haftalik eng past
2,73 €
Aksiya boʻyicha daromad
-1,11 €
Muomaladagi aksiyalar
148,72Â mln
Xodimlar soni
4Â ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
AD HOC NEWS
·
7 soat oldin
Evotec loses research chief. Evotec stock falls 2.03 percent
AD HOC NEWS
·
1 kun oldin
Evotec loses research chief and Evotec stock gains 2.36 percent
AD HOC NEWS
·
2 kun oldin
Evotec loses research chief. Evotec stock gains 2.05 percent
AD HOC NEWS
·
2 kun oldin
Evotec stock reports weaker 2026 guidance ahead of results
Profil
Evotec SE is a publicly listed drug discovery and development company headquartered in Hamburg, Germany. The company operates globally, largely through external alliances with pharmaceutical and biotechnology companies, academic institutions, patient advocacy groups, and venture capitalists. As of 31 December 2021 Evotec had a market capitalization of €7.5 billion and a pipeline of more than 130 partnered programs in discovery, pre-clinical development and clinical development.
The company's 4,200+ employees work across a number of therapeutic areas including CNS/neurology, metabolic diseases, Cancer, and inflammatory and infectious diseases. It has long-term discovery alliances with Bristol Myers Squibb, Bayer, Sanofi, Boehringer Ingelheim, the CHDI Foundation, Lilly, Takeda, Sernova, and more.
On 28 October 2009 the company was listed on the TecDAX index, which tracks the performance of the 30 largest German companies from the technology sector. On 24 September 2018 Evotec joined the MDAX index, following a rule change that enabled dual listing. The MDAX tracks 60 Prime Standard shares from sectors excluding technology. Wikipedia
Evotec SE haqida